Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
3126
Nebius Group N.V.
NBIS
$72.9B
| $1.26M | ﹤0.01% |
22,861
-416,079
| -95% | -$14.3M |
|
3127
Ichor Holdings
ICHR
$2.62B
| $1.26M | ﹤0.01% |
64,404
+21,830
| +51% | +$400K |
|
|
KC
3128
Kingsoft Cloud Holdings
KC
$3.5B
| $1.26M | ﹤0.01% |
+100,775
| New | +$1.3M |
|
3129
CALL
Blackrock
BLK
$182B
| $1.26M | ﹤0.01% |
+1,200
| New | +$1.13M |
|
|
GOOD
3130
Gladstone Commercial Corp
GOOD
$641M
| $1.26M | ﹤0.01% |
87,860
+27,776
| +46% | +$394K |
|
|
TRTX
3131
TPG RE Finance Trust
TRTX
$619M
| $1.26M | ﹤0.01% |
162,807
-99,484
| -38% | -$759K |
|
3132
Arbutus Biopharma
ABUS
$912M
| $1.26M | ﹤0.01% |
406,558
+180,393
| +80% | +$599K |
|
3133
Enviri
NVRI
$572M
| $1.26M | ﹤0.01% |
144,722
+44,785
| +45% | +$328K |
|
|
ITOS
3134
DELISTED
iTeos Therapeutics
ITOS
| $1.26M | ﹤0.01% |
125,996
-2,981
| -2% | -$24K |
|
3135
Midland States Bancorp
MSBI
$698M
| $1.26M | ﹤0.01% |
72,482
+15,855
| +28% | +$268K |
|
3136
Civista Bancshares
CIVB
$601M
| $1.26M | ﹤0.01% |
54,105
+8,507
| +19% | +$185K |
|
|
GNTY
3137
DELISTED
Guaranty Bancshares
GNTY
| $1.25M | ﹤0.01% |
29,470
+6,066
| +26% | +$245K |
|
|
UHT
3138
Universal Health Realty Income Trust
UHT
$576M
| $1.25M | ﹤0.01% |
31,189
+14,052
| +82% | +$553K |
|
3139
MediaAlpha
MAX
$837M
| $1.24M | ﹤0.01% |
113,648
+50,500
| +80% | +$487K |
|
3140
Tronox
TROX
$963M
| $1.24M | ﹤0.01% |
245,262
+96,947
| +65% | +$528K |
|
3141
Microvast
MVST
$332M
| $1.24M | ﹤0.01% |
342,323
+342,321
| +17,116,050% | +$1M |
|
3142
uniQure
QURE
$3.25B
| $1.24M | ﹤0.01% |
89,014
+21,270
| +31% | +$286K |
|
3143
Liberty Live Group Series C
LLYVK
$10B
| $1.24M | ﹤0.01% |
15,284
-2,567
| -14% | -$189K |
|
3144
Hudbay
HBM
$11.9B
| $1.24M | ﹤0.01% |
116,833
+17,969
| +18% | +$150K |
|
3145
First Bank
FRBA
$466M
| $1.24M | ﹤0.01% |
79,858
+21,955
| +38% | +$318K |
|
3146
Peapack-Gladstone Financial
PGC
$820M
| $1.24M | ﹤0.01% |
43,728
+15,183
| +53% | +$417K |
|
3147
Arcturus Therapeutics
ARCT
$222M
| $1.23M | ﹤0.01% |
94,793
+47,266
| +99% | +$559K |
|
3148
FTAI Infrastructure
FIP
$553M
| $1.23M | ﹤0.01% |
199,815
+74,294
| +59% | +$376K |
|
3149
Manitowoc
MTW
$758M
| $1.23M | ﹤0.01% |
102,136
+32,790
| +47% | +$322K |
|
3150
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $1.23M | ﹤0.01% |
27,771
+1,479
| +6% | +$64.4K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.